Bulls & Betrayal

Ultra Clean Holdings $UCTT promised explosive semiconductor growth in China—then stunned the market with a surprise earnings drop and a 28% stock plunge. On this episode of Bulls and Betrayal, Anna and Nate dig into the class action lawsuit alleging $UCTT hid slowdowns, inventory issues, and customer ramp failures behind bullish calls and inflated forecasts. For tech investors, market skeptics, and finance truth-seekers, this is mu...

Solaris Energy Infrastructure $SEI turned heads with a $400M acquisition—of a company with no employees, no real assets, and ties to a convicted felon. In this episode of Bulls and Betrayal, Anna and Nate dissect the shocking class action lawsuit alleging Solaris misled investors about MER’s legitimacy, cooked depreciation math, and hid toxic baggage (literally). Perfect for shareholders, corporate governance junkies, and true cri...

Open Lending $LPRO promised fintech innovation and bulletproof loan modeling—then reported a shocking $57M revenue loss and a 57% stock crash. In this episode of Bulls and Betrayal, Anna and Nate dig into the class action lawsuit alleging $LPRO misled investors with inflated profit share projections and flawed credit risk models. If you're into fintech, auto lending, or financial transparency, this one's for you. We break down earn...

Napco Security Technologies $NSSC promised soaring margins and booming hardware sales—but was it all smoke and mirrors? This week on Bulls and Betrayal, Anna and Nate unpack the class action lawsuit alleging $NSSC misled investors with inflated forecasts and faulty financial guidance. If you’re an investor, market skeptic, or just love seeing corporate facades crack, this one’s for you. We dig into earnings calls, margin promises, ...

NET Power $NPWR claimed it had a zero-emission power plant lighting the way to a green future. But was their La Porte demo site even running? In this episode of Bulls and Betrayal, Anna and Nate expose the shareholder lawsuit alleging $NPWR misrepresented key facts during its SPAC merger. Perfect for retail investors, clean energy enthusiasts, and legal watchers. Expect deep dives, timeline breakdowns, and corporate accountability—...

Zenas BioPharma $ZBIO dazzled Wall Street with its biotech promise—but did it deceive investors from the start? This week on Bulls and Betrayal, Anna and Nate unravel the class action lawsuit claiming $ZBIO overstated its financial runway and misled buyers during its 2024 IPO. If you're a retail investor, legal aficionado, or just love a juicy Wall Street exposé, this one’s for you. Expect sharp commentary, deep dives, and accounta...

🌿 CGC in the Weeds How Canopy Growth Lost 529 Million in Inventory WriteDowns

This week on Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate unpack the lawsuit facing Canopy Growth Corporation (Ticker: CGC). With a shocking $529 million inventory write-down and a net loss of $648 million, investors are alleging they were misled—and they’re fighting back.

Perfect for cannabis investors, legal watchers, and financia...

💊 $VTRS Vanishing Act The 26 Billion Dollar Write-Down Wall Street Forgot to Mention

In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate unravel the Viatris Inc (Ticker: $VTRS) merger drama—where bold earnings talk clashed with a stunning $25.8 billion goodwill impairment on the very same day. Was it poor communication, or a case of corporate misdirection?

Perfect for investors, compliance pros, a...

$TMCI Trouble Toe-Tal: The Bunion Scandal Wall Street Didn’t See Coming

In this explosive episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate dive into the class action lawsuit shaking up Treace Medical Concepts Inc (Ticker: $TMCI). Allegations of securities fraud, misleading investor claims, and “bunion-sized” deception over their Lapiplasty system make this a case investors can’t ignore.

Perfect for inve...

🎙️Title: "BBAI - When AI Gets Audited: BigBear’s Accounting Faceplant"

When BigBear.ai ($BBAI) stumbled over basic accounting, investors didn’t just lose money they lost trust. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate dig into how one of the hottest AI stocks misapplied bifurcated accounting, misled the markets, and sparked a class-action lawsuit. If you’re a retail investor, stock mark...

AbbVie offers $45 a share. Just weeks earlier, Bain buys millions of Cerevel (CERE) shares at $22.81. Coincidence or insider edge? In this explosive episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate dive into a biotech merger turning heads in court. If you’re an investor, legal buff, or just love corporate drama, this episode is for you. Expect class action twists, SPAC games, and profit plays that smell...

What happens when a company allegedly hides a $200M valuation before selling for just $110M? In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we dive into the ECG Management Consultants lawsuit. Nate and Anna unpack allegations of fiduciary breaches, hidden valuations, and shareholder deception—all without a stock ticker in sight. Perfect for investors, finance sleuths, and corporate accountability junkies. E...

Constellation Brands (STZ), the powerhouse behind Corona and Meiomi, is facing a bombshell securities fraud lawsuit—and we’re diving deep into the billions at stake. This episode of Bulls & Betrayal unpacks how overly rosy projections about their wine and spirits business may have misled investors. Stockholders lost big, and now they’re fighting back.

Perfect for retail investors, finance followers, and anyone hooked on corpora...

Quantum Computing Inc. ($QUBT) promised futuristic tech, NASA deals, and chip foundries—but investors may have bought into fiction, not function. In this Bulls & Betrayal episode, we uncover how a startup hyped a “quantum leap” only to be hit with a class action lawsuit for alleged fraud, fake revenue, and phantom facilities.

If you're a retail investor, tech optimist, or just love a good financial exposé, you won’t want to mis...

Manhattan Associates ($MANH) looked unstoppable—record revenue, booming cloud growth, and bold projections. But behind the scenes, they were allegedly hyping a services segment they knew couldn’t deliver. This episode of Bulls & Betrayal dives into the class action lawsuit claiming misleading guidance led to a brutal 24.49% stock crash and major investor losses.

If you're into SaaS stocks, corporate accountability, or Wall Stre...

Zynex ($ZYXI) made headlines for more than just back pain relief — a new class action lawsuit alleges they sent patients excessive medical supplies to inflate revenues, sparking insurance backlash and a stock collapse. From padded bills to Tricare suspensions, this episode of Bulls & Betrayal uncovers how a billing scheme may have zapped shareholder value.

If you're into healthcare stocks, investor rights, or scandalous financi...

Sana Biotechnology ($SANA) claimed a long cash runway and a thriving clinical pipeline — but investors were blindsided when two flagship programs were scrapped and nearly a third of the workforce got cut. In this episode of Bulls & Betrayal, we dissect the timeline, the SEC filings, and the class action lawsuit that’s now accusing Sana of securities fraud.

Perfect for biotech investors, legal junkies, and financial sleuths, thi...

SoundHound AI ($SOUN) went from powering voice assistants to facing a full-blown shareholder class action lawsuit — and this episode breaks down how it all unraveled. From botched acquisitions and internal control failures to a stock drop and SEC filings, we're diving into what really happened behind the scenes.

If you're an investor, finance nerd, legal junkie, or startup watcher, this one's for you. Expect deep dives, sharp comme...

Grocery Outlet (GO) promised a smooth systems upgrade—but investors got a rude awakening when stock prices plummeted nearly 20% overnight. In this episode of Bulls & Betrayal, Anna and Nate unpack how a botched tech rollout, misleading statements, and delayed admissions led to a federal securities class action lawsuit. Was it corporate misstep... or deception?

Perfect for retail investors, watchdogs, and anyone tracking corpora...